These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 35409153)

  • 21. Genetic diagnosis of hypertrophic cardiomyopathy using mass spectrometry DNA arrays and high resolution melting.
    Santos S; Lança V; Oliveira H; Branco P; Silveira L; Marques V; Brito D; Madeira H; Bicho M; Fernandes AR
    Rev Port Cardiol; 2011 Jan; 30(1):7-18. PubMed ID: 21425739
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circulating microRNAs as biomarkers for diffuse myocardial fibrosis in patients with hypertrophic cardiomyopathy.
    Fang L; Ellims AH; Moore XL; White DA; Taylor AJ; Chin-Dusting J; Dart AM
    J Transl Med; 2015 Sep; 13():314. PubMed ID: 26404540
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MYH7B variants cause hypertrophic cardiomyopathy by activating the CaMK-signaling pathway.
    Chen P; Li Z; Nie J; Wang H; Yu B; Wen Z; Sun Y; Shi X; Jin L; Wang DW
    Sci China Life Sci; 2020 Sep; 63(9):1347-1362. PubMed ID: 32207065
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lack of Phenotypic Differences by Cardiovascular Magnetic Resonance Imaging in MYH7 (β-Myosin Heavy Chain)- Versus MYBPC3 (Myosin-Binding Protein C)-Related Hypertrophic Cardiomyopathy.
    Weissler-Snir A; Hindieh W; Gruner C; Fourey D; Appelbaum E; Rowin E; Care M; Lesser JR; Haas TS; Udelson JE; Manning WJ; Olivotto I; Tomberli B; Maron BJ; Maron MS; Crean AM; Rakowski H; Chan RH
    Circ Cardiovasc Imaging; 2017 Feb; 10(2):. PubMed ID: 28193612
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blood-based microRNA signatures differentiate various forms of cardiac hypertrophy.
    Derda AA; Thum S; Lorenzen JM; Bavendiek U; Heineke J; Keyser B; Stuhrmann M; Givens RC; Kennel PJ; Schulze PC; Widder JD; Bauersachs J; Thum T
    Int J Cardiol; 2015 Oct; 196():115-22. PubMed ID: 26086795
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical phenotypic characteristics in patients carrying MYH7-R143Q mutation with hypertrophic cardiomyopathy.
    Zhang L; Zhang Y; Wang J; Ta S; Zhao J; Yao L; Han C; Liu J; Zhao X; Yuan J; Li R; Shan B; Wang Y; Qin Y; Wang B; Liu L
    Curr Probl Cardiol; 2024 Jan; 49(1 Pt C):102164. PubMed ID: 37907184
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Unexpectedly low mutation rates in beta-myosin heavy chain and cardiac myosin binding protein genes in Italian patients with hypertrophic cardiomyopathy.
    Roncarati R; Latronico MV; Musumeci B; Aurino S; Torella A; Bang ML; Jotti GS; Puca AA; Volpe M; Nigro V; Autore C; Condorelli G
    J Cell Physiol; 2011 Nov; 226(11):2894-900. PubMed ID: 21302287
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence and Phenotypic Expression of Mutations in the MYH7, MYBPC3 and TNNT2 Genes in Families with Hypertrophic Cardiomyopathy in the South of Brazil: A Cross-Sectional Study.
    Mattos BP; Scolari FL; Torres MA; Simon L; Freitas VC; Giugliani R; Matte Ú
    Arq Bras Cardiol; 2016 Sep; 107(3):257-265. PubMed ID: 27737317
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic variations of beta-MYH7 in Venezuelan patients with hypertrophic cardiomyopathy.
    Rodríguez R; Guerrero D; Rivas Y; Lacruz A; Flores Y
    Invest Clin; 2014 Mar; 55(1):23-31. PubMed ID: 24758099
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Resequencing the whole MYH7 gene (including the intronic, promoter, and 3' UTR sequences) in hypertrophic cardiomyopathy.
    Coto E; Reguero JR; Palacín M; Gómez J; Alonso B; Iglesias S; Martín M; Tavira B; Díaz-Molina B; Morales C; Morís C; Rodríguez-Lambert JL; Corao AI; Díaz M; Alvarez V
    J Mol Diagn; 2012 Sep; 14(5):518-24. PubMed ID: 22765922
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Spectrum of Mutations in Hypertrophic Cardiomyopathy Genes Among Tunisian Patients.
    Jaafar N; Gómez J; Kammoun I; Zairi I; Amara WB; Kachboura S; Kraiem S; Hammami M; Iglesias S; Alonso B; Coto E
    Genet Test Mol Biomarkers; 2016 Nov; 20(11):674-679. PubMed ID: 27574918
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Absence of known feline MYH7 and MYBPC3 variants in a diverse cohort of cats with hypertrophic cardiomyopathy.
    O'Donnell K; Adin D; Atkins CE; DeFrancesco T; Keene BW; Tou S; Meurs KM
    Anim Genet; 2021 Aug; 52(4):542-544. PubMed ID: 33970514
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intrinsic MYH7 expression regulation contributes to tissue level allelic imbalance in hypertrophic cardiomyopathy.
    Montag J; Syring M; Rose J; Weber AL; Ernstberger P; Mayer AK; Becker E; Keyser B; Dos Remedios C; Perrot A; van der Velden J; Francino A; Navarro-Lopez F; Ho CY; Brenner B; Kraft T
    J Muscle Res Cell Motil; 2017 Aug; 38(3-4):291-302. PubMed ID: 29101517
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical and ECG variables to predict the outcome of genetic testing in hypertrophic cardiomyopathy.
    Robyns T; Breckpot J; Nuyens D; Vandenberk B; Corveleyn A; Kuiperi C; Van Aelst L; Van Cleemput J; Willems R
    Eur J Med Genet; 2020 Mar; 63(3):103754. PubMed ID: 31513939
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression patterns of cardiac myofilament proteins: genomic and protein analysis of surgical myectomy tissue from patients with obstructive hypertrophic cardiomyopathy.
    Theis JL; Bos JM; Theis JD; Miller DV; Dearani JA; Schaff HV; Gersh BJ; Ommen SR; Moss RL; Ackerman MJ
    Circ Heart Fail; 2009 Jul; 2(4):325-33. PubMed ID: 19808356
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic screening for hypertrophic cardiomyopathy in large, asymptomatic military cohorts.
    Brough J; Jain M; Jerves T; Kruszka P; McGuffey E
    Am J Med Genet C Semin Med Genet; 2020 Mar; 184(1):124-128. PubMed ID: 32030882
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A new common mutation in the cardiac beta-myosin heavy chain gene in Finnish patients with hypertrophic cardiomyopathy.
    Jääskeläinen P; Heliö T; Aalto-Setälä K; Kaartinen M; Ilveskoski E; Hämäläinen L; Melin J; Kärkkäinen S; Peuhkurinen K; Nieminen MS; Laakso M; ; Kuusisto J
    Ann Med; 2014 Sep; 46(6):424-9. PubMed ID: 24888384
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Somatic MYH7, MYBPC3, TPM1, TNNT2 and TNNI3 mutations in sporadic hypertrophic cardiomyopathy.
    Núñez L; Gimeno-Blanes JR; Rodríguez-García MI; Monserrat L; Zorio E; Coats C; McGregor CG; Hernandez del Rincón JP; Castro-Beiras A; Hermida-Prieto M
    Circ J; 2013; 77(9):2358-65. PubMed ID: 23782526
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The genotype-phenotype correlation of MYH7 gene G15391A mutation and MYBPC3 gene G12101A mutation in familial hypertrophic cardiomyopathy].
    WANG H; ZOU YB; WANG JZ; SONG L; SUN K; SONG XD; WANG XJ; ZHANG CN; HUI RT
    Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Dec; 36(12):1059-62. PubMed ID: 19134269
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gene-specific increase in the energetic cost of contraction in hypertrophic cardiomyopathy caused by thick filament mutations.
    Witjas-Paalberends ER; Güçlü A; Germans T; Knaapen P; Harms HJ; Vermeer AM; Christiaans I; Wilde AA; Dos Remedios C; Lammertsma AA; van Rossum AC; Stienen GJ; van Slegtenhorst M; Schinkel AF; Michels M; Ho CY; Poggesi C; van der Velden J
    Cardiovasc Res; 2014 Jul; 103(2):248-57. PubMed ID: 24835277
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.